WO1999007332A2 - A natural eubiotic product for maintenance and treatment of teguments - Google Patents

A natural eubiotic product for maintenance and treatment of teguments Download PDF

Info

Publication number
WO1999007332A2
WO1999007332A2 PCT/RO1998/000014 RO9800014W WO9907332A2 WO 1999007332 A2 WO1999007332 A2 WO 1999007332A2 RO 9800014 W RO9800014 W RO 9800014W WO 9907332 A2 WO9907332 A2 WO 9907332A2
Authority
WO
WIPO (PCT)
Prior art keywords
product
strain
eubiotic
strains
teguments
Prior art date
Application number
PCT/RO1998/000014
Other languages
French (fr)
Other versions
WO1999007332A3 (en
Inventor
Rodica Teodorescu
Original Assignee
Rodica Teodorescu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rodica Teodorescu filed Critical Rodica Teodorescu
Priority to AU87539/98A priority Critical patent/AU8753998A/en
Publication of WO1999007332A2 publication Critical patent/WO1999007332A2/en
Publication of WO1999007332A3 publication Critical patent/WO1999007332A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/007Preparations for dry skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin

Definitions

  • the present invention relates to an natural eubiotic product for the maintenance and treatment of teguments.
  • the skin is not a mere body coating, but a living organ having a vital importance for the body.
  • the sebum secretion is decreasing and the skin begins to dry, being able no more to accomplish its functions.
  • the skin acidity is a defense factor of the body against the environment influences, especially of micro-organisms that do not favourably grow in an acid medium.
  • the pH of teguments and, especially, that of complexion easily modifies as a result of the non-respecting of hygiene rules, of sudden temperature variations, inadequate nourishment, constipation, stress.
  • the pH of complexion modifies as a result of the excess of soap use, of alkaline face lotions, concentrated glycerine, concentrated alcoholic lotions.
  • li is well known the use of lactic acid in cosmetics, in preparations for skin maintenance, especially for modifying the pH of teguments.
  • the used lactic acid is usually a syntesis product and the skin acidification, in physiological limits, is hard to be obtained as is less biologically compatible with the functions of teguments.
  • the common Lb. acidophylus strains are also inadequate for a direct use in cosmetics as they are too less resistant to cosmetic compositions, and because of their firm and spinning aspect, they produce the change of the cosmetic product, being very important for the product user.
  • the eubiotic product consists of a mixture of three Lactobacillus acidophylus LD, LV and LD strains, registered in the Biosan Centre Collection Bucharest under nos.13, 17 and 11, the association being in equal parts from each strain before the mixture lyophilisation.
  • the Lactobacillus acidophylus LD-11 strain ferments the raffinose.
  • the Lactobacillus acidophylus LR-13 strain ferments the trehalose.
  • the Lactobacillus acidophylus LV-17 ferments the dextrine.
  • the three associated lactic bacilli strains are used as active ingredients in different cosmetic forms for the maintenance and treatment of teguments, the product being included in amount of 1 - 10 g. under the lyophilised form at 100 g. of cosmetic product.
  • the three bacteria strains are associated, before lyophilisation, in equal parts.
  • Lactobacillus acidophylus common strains are the following: a) Morphological characteristics:
  • Lactobacillus acidophylus appears as sticks with rounded ends, Gram positive, organized in filamentous groups of variable dimensions, giving a filamentous and mucilaginous aspect to the growing medium. b) Cultural characteristics
  • solid MRS medium On solid media (solid MRS medium), they can develop on the surface forming long, tangled, gluey colonies, with filiform, fluffy projections, or in depth, where the colonies are small, irregular, with fine prolongations.
  • the culture is not haemolytic on blood media
  • the aspect that the present invention solves consists in finding an optimum association of Lactobacillus acidophylus anallergical strains for realizing a natural eubiotic product, capable of improving the pH of teguments, approaching it to the physiological one of 5,5 and to be resistant in cosmetic compositions.
  • the product, according to the invention consists of a mixture of three Lactobacillus acidophylus strains, in equal parts each, the three strains being registered in the Biosan Centre Collection Bucharest with denomination LR, LV and LD, under the nos. 13, 17 and 11.
  • lactobacillus pure strains have been obtained by repeated dispersions and isolations on agar media, known per se, that contain growing substances and inhibitory substances for other strains of micro-organisms.
  • the Lb. acidophylus strains having the following characteristics are identified and isolated from the culture media:
  • LD strain no.11 Morphological characteristics - they are long bacilli, intermittently coloured, immobile but forming short chains. At the colouring with methylene blue, they appear as long bacilli, intermittently coloured, immobile, forming short chains. b) Cultural characteristics - they coagulate the milk on litmus milk and they disturb the medium on a MRS liquid medium. On a solid MRS medium, the colonies are small, whitish and gluey, with irregular margins. c) Bio-chemical characteristics:
  • the culture is not haemolytic on blood media; - they coagulate the milk and are homofermentative;
  • the acid power is of I ⁇ ' and the limit acidity is of 1 ,3% in lactic acid;
  • the culture is not haemolytic on blood media
  • the fermentation of trehalose is a characteristic of this strain.
  • the acid power is of 173°T and the limit acidity is of 1 ,4% in lactic acid;
  • the culture is not haemolytic on blood media
  • the identified and isolated strains, according to the invention, can be characterised as being different from the Lb. acidophylus common strains by the following:
  • the identified and isolated strains will be maintained on synthetic media such as MRS, having the following composition: 10 g of tryptone, 10 g of extract of meat, 5 g of extract of yeast, 20 g of glucose, 2 g of disodium phosphate, 5 g of sodium acetate, 2 g of sodium citrate, 0,05 g of magnesium sulphate, 1000 ml of distilled water.
  • synthetic media such as MRS, having the following composition: 10 g of tryptone, 10 g of extract of meat, 5 g of extract of yeast, 20 g of glucose, 2 g of disodium phosphate, 5 g of sodium acetate, 2 g of sodium citrate, 0,05 g of magnesium sulphate, 1000 ml of distilled water.
  • the strains are submitted to the most important known tests of identification in order to find out the resistance in time of the respective strains, their ageing speed.
  • the strains are periodically passed on solid media, by methods known per se.
  • the sterile degreased milk is also the used protecting medium, according to the invention, for the last stage of process, namely the lyophilisation of the three multiplied strains. A pure culture of the three strains is obtained.
  • the lactobadlli culture obtained according to the invention, is congelated at -45 O - 50°C, the proper lyophilization being started afterwards.
  • the lyophilzation is realized in vacuum of 3 tonrduring 30 hours, having as protection medium the sterile degreased milk corresponding to physical, chemical and micro-biological standards (lack of heavy metals etc).
  • the lyophilised product is conditioned in special containers, in asepsis conditions (work under hood) and their closing is realized in vacuum.
  • the lyophilised product obtained according to the invention, has the following characteristics that identify it:
  • each Lb.acidophylus bacilli strain is identified by the morphological, cultural and bio-chemical characteristics presented according to the invention
  • the lyophilised product may be used for manufacturing the creams for all types of complexion, the demaking-up milk and the cosmetic face masks.
  • Examples of cosmetics containg the eubiotic product:
  • 10 g of lyophilised eubiotic product 20 g of anhydre lanoline, 10 g of cetaceum, 10 g of stearine, 10 g of helianti oils, 30 g of boraxed water, 30 g of distilled water.
  • the above-mentioned cosmetic products do not limit the use of the product according to this invention with a view to obtaining other types of cosmetic products such as the demaking-up milk, the hydration cream etc.
  • the content of 1 - 2 bottles, containing the lyophilised eubiotic product, is dissolved in a small quantity of boiled and cooled water in which a clean gauze tissue is impregnated and it is applied on the face, the complexion being, beforehand, washed with lukewarm water (37...40°C).
  • the face mask is maintained on the face 30 minutes - 1 hour, the person being at total rest.
  • a bottle per os is taken in the morning, on an empty stomach, before meals, and the face mask is applied in the evening.
  • the treatment takes 10...15 days, depending on the complexion alteration.

Abstract

The eubiotic product, according to the invention, is constituted of a mixture of three Lactobacillus acidophylus LR, LV and LD strains, registered in the Biosan Centre Collection Bucharest under the nos. 13, 17 and 11, the association being in equal parts of each strain before lyophilisation of mixture. The Lactobacillus acidophylus LD-11 strain ferments the raffinose. The Lactobacillus acidophylus LR-13 strain ferments the trehalose. The Lactobacillus acidophylus LV-17 strain ferments the dextrine. The three associated lactic bacilli strains are used as active ingredients in different cosmetic forms for the maintenance and treatment of teguments, the product being included in amount of 1-10 g under lyophilised form at 100 g of cosmetic product.

Description

A NATURAL EUBIOTIC PRODUCT FOR THE MAINTENANCE AND TREATMENT
OF TEGUMENTS
The present invention relates to an natural eubiotic product for the maintenance and treatment of teguments.
It is known that the skin is not a mere body coating, but a living organ having a vital importance for the body.
By age, the sebum secretion is decreasing and the skin begins to dry, being able no more to accomplish its functions. The sebum, together with other skin secretions, forms the so-called "acid casing" of the skin whose acidity is varying from person to person.
The skin acidity is a defense factor of the body against the environment influences, especially of micro-organisms that do not favourably grow in an acid medium.
If the skin is lacking this protecting acid casing, abscesses, furuncules, mycosis etc. can frequently appear.
The pH of teguments and, especially, that of complexion, easily modifies as a result of the non-respecting of hygiene rules, of sudden temperature variations, inadequate nourishment, constipation, stress. At the same time, the pH of complexion modifies as a result of the excess of soap use, of alkaline face lotions, concentrated glycerine, concentrated alcoholic lotions. li is well known the use of lactic acid in cosmetics, in preparations for skin maintenance, especially for modifying the pH of teguments. The used lactic acid is usually a syntesis product and the skin acidification, in physiological limits, is hard to be obtained as is less biologically compatible with the functions of teguments.
For obtaining the natural lactic acid, it is known, in food industry, the use of Lactobacillus acidophylus strains. For using the natural lactic acid, this one should be isolated from the culture medium, as purely as possible, implying complex technologies.
The common Lb. acidophylus strains are also inadequate for a direct use in cosmetics as they are too less resistant to cosmetic compositions, and because of their firm and spinning aspect, they produce the changement of the cosmetic product, being very important for the product user.
It is also known the use of a drug consisting of a mixture of two Lactobacillus acidophylus and Lactobacillus casei bacteria strains, registered in the IISB collection - Bucharest under nos.3 and 7. The eubiotic product, according to the invention, consists of a mixture of three Lactobacillus acidophylus LD, LV and LD strains, registered in the Biosan Centre Collection Bucharest under nos.13, 17 and 11, the association being in equal parts from each strain before the mixture lyophilisation.
The Lactobacillus acidophylus LD-11 strain ferments the raffinose. The Lactobacillus acidophylus LR-13 strain ferments the trehalose. The Lactobacillus acidophylus LV-17 ferments the dextrine. The three associated lactic bacilli strains are used as active ingredients in different cosmetic forms for the maintenance and treatment of teguments, the product being included in amount of 1 - 10 g. under the lyophilised form at 100 g. of cosmetic product.
The eubiotic advantages, according to the invention, are the following:
- it is easily obtainable from natural, easily accesible ingredients, it destroys the pathogenic microflora and maintains the pH at physiological values, not producing allergies and inflammations;
- it tones up and renders the flexibility of teguments by "ergons" as a result of the activity, it develops a non-specific immunity and inhibits the growing of different microbial agents by the pH that it grows - the no passing barrier for other micro-organisms;
- it is the active compound of cosmetic products being the only that approaches the physiological chemistry of teguments.
It is given hereunder a example of realization of the invention. For obtaining the eubiotic product, according to the present invention, the three bacteria strains are associated, before lyophilisation, in equal parts.
The characteristics of Lactobacillus acidophylus common strains are the following: a) Morphological characteristics:
Following the Gram colouring, Lactobacillus acidophylus appears as sticks with rounded ends, Gram positive, organized in filamentous groups of variable dimensions, giving a filamentous and mucilaginous aspect to the growing medium. b) Cultural characteristics
On solid media (solid MRS medium), they can develop on the surface forming long, tangled, gluey colonies, with filiform, fluffy projections, or in depth, where the colonies are small, irregular, with fine prolongations.
On MRS liquid, they form, after 48 hours, a fine, fluffy sediment. „„„.,„ O 99/07332
c) Biochemical characteristics:
- resistance to inhibitory substances 3,5% - NaCI;
- sodium taurocolate 3%;
- phenol 0,4%; - acid power 140°T;
- limit acidity 1,2% lactic acid:
- they do not fluid the gelatine;
- they do not hydrolize the starch;
- they do not reduce the nitrates;
- they reduce the tincture of litmus and the methylene blue;
- they do not produce indole, sulphuric acid, arginine, ammonia;
- they are urease and catalase negative;
- the culture is not haemolytic on blood media;
- they coagulate the milk and are homofermentative;
- they produce acetylmethylcarbinol;
- they do not use the sodium citrate;
- they ferment the glucose, lactose, saccharose, fructose, galactose, manose, maltose;
- they do not ferment the dextrine, trehalose and raffinose;
- they produce lactic acid optically inactive and volatile acids as a result of sugars fermentation;
- a visible growth on media lacking carbon hydrates is not noticed; d) Temperature relations - The optimum growing temperature is 371. They do not grow under 20°C. The maximum temperature at which they can normally grow is 43...45°C. They can resist 30 minutes at 60°C.
The attempts for using these strains in cosmetic products have not lead to optimum results, therefore, by tests, it has been attempted and realized the selection and isolation of some Lactobacillus acidophylus strains to be compatible for the preparation of cosmetic products for the maintenance of teguments.
The aspect that the present invention solves consists in finding an optimum association of Lactobacillus acidophylus anallergical strains for realizing a natural eubiotic product, capable of improving the pH of teguments, approaching it to the physiological one of 5,5 and to be resistant in cosmetic compositions. The product, according to the invention, consists of a mixture of three Lactobacillus acidophylus strains, in equal parts each, the three strains being registered in the Biosan Centre Collection Bucharest with denomination LR, LV and LD, under the nos. 13, 17 and 11.
Modality for obtaining the strains
The lactobacillus pure strains have been obtained by repeated dispersions and isolations on agar media, known per se, that contain growing substances and inhibitory substances for other strains of micro-organisms.
The Lb. acidophylus strains having the following characteristics are identified and isolated from the culture media:
1. LD strain no.11 a) Morphological characteristics - they are long bacilli, intermittently coloured, immobile but forming short chains. At the colouring with methylene blue, they appear as long bacilli, intermittently coloured, immobile, forming short chains. b) Cultural characteristics - they coagulate the milk on litmus milk and they disturb the medium on a MRS liquid medium. On a solid MRS medium, the colonies are small, whitish and gluey, with irregular margins. c) Bio-chemical characteristics:
- the maximum growing temperature is 47°C;
- they resist 30 minutes at 60°;
- resistance at inhibitory substances a) NaCI - 6%; b) Sodium taurocolate - 3%; c) Phenol - 0,6%
- acid power - final acidity of culture 170°T
- limit acidity in lactic acid 1 ,4%
- they do not fluid the gelatine;
- they do not hydrolize the starch;
- they do not reduce the nitrates;
- they reduce the tincture of litmus and the methylene blue;
- they do not produce indole, sulphuric acid and arginine;
- they are urease and catalase negative;
- the culture is not haemolytic on blood media; - they coagulate the milk and are homofermentative;
- they produce acetylmethylcarbinol;
- they do not use the sodium citrate;
- they ferment the glucose, lactose, saccharose, fructose, galactose, manose. The fermentation of raffinose is a characteristic of this strain.
2. LR strain no.13 a) Moφhological characteristics - long and thin ba lli, forming, nevertheless, short chains, intensely coloured. They are immobile and have rounded ends.
At the colouring with methylene blue, there appear as thin, long bacilli, with rounded ends, immobile. They form short chains, intensely coloured. b) Cultural characteristics
- they coagulate and acidulate the milk on litmus milk;
- they disturb the medium on liquid MRS medium and form a sediment at 48 hours;
- on solid MRS medium, the surface colonies appear delicate, long, with fluffy projections and a small and dark centre. The depth colonies appear small, irregular, whitish with fine ramified or radial prolongations. c) Bio-chemical characteristics
- the maximum growing temperature is at 48°C;
- resistance at 60°;
- the acid power is of Iδδ' and the limit acidity is of 1 ,3% in lactic acid;
- resistance at the following inhibitory substances: a) NaCI - they grow no more over 8%; b) Sodium taurocolate - they grow no more over 4%; c) Phenol - the growth is very poor over 0,8%.
- they do not fluid the gelatine;
- they do not hydrolize the starch;
- they do not reduce the nitrates;
- they reduce the tincture of litmus and the methylene blue;
- they do not produce indole, sulphuric acid, ammonia and arginine;
- they are urease and catalase negative;
- the culture is not haemolytic on blood media;
- they coagulate the milk and are homofermentative;
- they produce acetylmethylcarbinol; „,„„,,.,
WO 99/07332
6
- they do not use the sodium citrate;
- they feiment the glucose, lactose, saccharose, fructose, galactose, manose, maltose.
The fermentation of trehalose is a characteristic of this strain.
3. LV strain no.17 a) Moφhological characteristics - short badlli, weakly coloured, immobile, forming short chains.
At the colouring with methylene blue, there appear short, weakly coloured bacilli, short chains, immobile, with rounded ends. b) Cultural characteristics - they coagulate and acidify the milk on litmus milk, in 18 hours after insemination; on liquid MRS medium, they disturb the medium forming a sediment; on solid MRS medium, the colonies are white, with smooth margins, presenting ramifications. c) Bio-chemical characteristics
- the maximum growing temperature is at 48°C;
- they resist 90 minutes at 60°;
- the acid power is of 173°T and the limit acidity is of 1 ,4% in lactic acid;
- resistance at inhibitory substances: a) NaCI - they grow no more over 8%; b) Sodium taurocolate - they grow no more over 4%; c) Phenol - they grow no more over 0,8%.
- they do not fluid the gelatine;
- they do not hydrolize the starch;
- they do not reduce the nitrates;
- they reduce the tincture of litmus and the methylene blue;
- they do not produce indole, sulphuric acid, ammonia and arginine;
- they are urease and catalase negative;
- the culture is not haemolytic on blood media;
- they coagulate the milk and are homofermentative;
- they produce acetylmethylcarbinol;
- they do not use the sodium citrate;
- they ferment the glucose, lactose, saccharose, fructose, galactose, manose, maltose. The fermentation of dextrine is a characteristic of this strain. The identified and isolated strains, according to the invention, can be characterised as being different from the Lb. acidophylus common strains by the following:
- they form short chains, very adequate for the homogeneity and resistance of cosmetic products where the eubiotic is included;
- they coagulate and acidify the milk more rapidly, leading to a faster diminution of pH from the medium where the strains are induded, either this one is a cosmetic product;
- they disturb evidently the liquid culture media and deposit in abundance, proving a great viability of the strain and a performing production;
- in comparison with the common strains, they ferment other sugars (trehalose, raffinose and dextrine) that the common strains do not ferment, proving a superior enzymatic package during the identification process;
- the grown resistance to dassic inhibitory substances proves a bigger viability of strains obtained according to the invention in comparison with the common strains.
The identified and isolated strains will be maintained on synthetic media such as MRS, having the following composition: 10 g of tryptone, 10 g of extract of meat, 5 g of extract of yeast, 20 g of glucose, 2 g of disodium phosphate, 5 g of sodium acetate, 2 g of sodium citrate, 0,05 g of magnesium sulphate, 1000 ml of distilled water.
Periodically, the strains are submitted to the most important known tests of identification in order to find out the resistance in time of the respective strains, their ageing speed.
In order to obtain the vitality, the strains are periodically passed on solid media, by methods known per se.
In order to prepare the strains for their production stage, these ones are passed on sterile degreased milk, in the association ratio of 1/3 of each strain at 10 litres of milk.
The sterile degreased milk is also the used protecting medium, according to the invention, for the last stage of process, namely the lyophilisation of the three multiplied strains. A pure culture of the three strains is obtained.
There have not been noticed phenomena of antagonism, of elimination of one strain by another between the lactobadllus strains, the number of viable germs from the pure culture being maximum.
The lactobadlli culture, obtained according to the invention, is congelated at -45 O - 50°C, the proper lyophilization being started afterwards. The lyophilzation is realized in vacuum of 3 tonrduring 30 hours, having as protection medium the sterile degreased milk corresponding to physical, chemical and micro-biological standards (lack of heavy metals etc).
The lyophilised product is conditioned in special containers, in asepsis conditions (work under hood) and their closing is realized in vacuum.
The lyophilised product, obtained according to the invention, has the following characteristics that identify it:
- aspect: lyophilised powder without mechanical impurities, hydroscopic;
- colour: white yellowish
- smell: specific
- taste: typically sour
- solubility: insoluble in water, but it easily disperses realizing a homogenous dispersion
- pH of suspension 1% in water: 3, 8...5, 5
- each Lb.acidophylus bacilli strain is identified by the morphological, cultural and bio-chemical characteristics presented according to the invention
- content in Cl"% in weight = max. 1 ,2
- content in Ca2+% in weight = min. 1,2
- content in nitrogen % in weight = min. 4,5
- calcination residues = max. 12% in weight
- absent heavy metals
- microbiological purity - according to Romanian Pharmacopeea
- number of viable germs = min. 5 x 107 germs/0,50 g
- validity period: 2 years
- the lyophilised product may be used for manufacturing the creams for all types of complexion, the demaking-up milk and the cosmetic face masks.
For the treatment of acnea complexion, simultaneously with the use of cosmetic face masks, it is administered per os, in the morning on an empty stomach, 30 minutes before meals (0,50 g or 2 tablets of 0,25 g).
Examples of cosmetics containg the eubiotic product:
Cream for dry complexion with lactic bacilli
2 g of lyophilised eubiotic product, 10 g of lanoline, 2 g of cetaceum, 5 g of vaseline, 0,1 g of cholesterol, 21 g of oleum helianti, 0,5 g of wax, 3 g of boraxed water, 50 g of distilled water. O 99/07332 y
Cream for αreasv complexion with lactic bacilli
10 g of lyophilised eubiotic product, 20 g of anhydre lanoline, 10 g of cetaceum, 10 g of stearine, 10 g of helianti oils, 30 g of boraxed water, 30 g of distilled water.
The above-mentioned cosmetic products do not limit the use of the product according to this invention with a view to obtaining other types of cosmetic products such as the demaking-up milk, the hydration cream etc.
Cosmetic face mask with lactobacilli
The content of 1 - 2 bottles, containing the lyophilised eubiotic product, is dissolved in a small quantity of boiled and cooled water in which a clean gauze tissue is impregnated and it is applied on the face, the complexion being, beforehand, washed with lukewarm water (37...40°C).
The face mask is maintained on the face 30 minutes - 1 hour, the person being at total rest.
For the acnea complexion, a bottle per os is taken in the morning, on an empty stomach, before meals, and the face mask is applied in the evening.
The treatment takes 10...15 days, depending on the complexion alteration.

Claims

C L A I M S
1. A natural eubiotic product for the maintenance and treatment of teguments comprising Lactobacillus, characterized in that is constituted of a mixture of three Lactobacillus acidophylus LR, LV and LD strains, registered in the Biosan Centre Collection - Bucharest under the nos. 13, 17 and, respectively, 11 , the association being made in equal parts of each strain, before lyophilisation of mixture.
2. A eubiotic product, according to claim 1, characterized in that the used Lactobacillus acidophylus LD-11 strain is the strain that ferments the raffinose.
3. A eubiotic product, according to claim 1, characterized in that the used Lactobacillus acidophylus LR-13 strain is the strain that ferments the trehalose.
4. A eubiotic product, according to claim 1 , characterized in that the used Lactobacillus acidophylus LV-17 strain is the strain that ferments the dextrine.
5. A eubiotic product, according to claims 1 - 4, characterized in that the three associated lactic bacilli strains are used as active ingredients in different cosmetic forms for the maintenance and treatment of teguments, the product being included in amount of 1...10 g under lyophilised form at 100 g of cosmetic product.
PCT/RO1998/000014 1997-08-05 1998-08-03 A natural eubiotic product for maintenance and treatment of teguments WO1999007332A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU87539/98A AU8753998A (en) 1997-08-05 1998-08-03 A natural eubiotic product for maintenance and treatment of teguments

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RO97-01480A RO113114B1 (en) 1997-08-05 1997-08-05 Natural eubiotic product for tegument maintenance and treatment
RO97-01480 1997-08-05

Publications (2)

Publication Number Publication Date
WO1999007332A2 true WO1999007332A2 (en) 1999-02-18
WO1999007332A3 WO1999007332A3 (en) 1999-04-29

Family

ID=20105385

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/RO1998/000014 WO1999007332A2 (en) 1997-08-05 1998-08-03 A natural eubiotic product for maintenance and treatment of teguments

Country Status (3)

Country Link
AU (1) AU8753998A (en)
RO (1) RO113114B1 (en)
WO (1) WO1999007332A2 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006136420A3 (en) * 2005-06-22 2007-04-19 Organobalance Gmbh Methods and means for protecting the skin against pathogenic microorganisms
US7510734B2 (en) 2004-03-04 2009-03-31 E-L Management Corporation Skin treatment method with Lactobacillus extract
WO2012118535A1 (en) 2011-03-01 2012-09-07 Quorum Innovations, Llc Materials and methods for treating conditions associated with pathogenic biofilm
US10953051B2 (en) 2005-06-22 2021-03-23 Novozymes A/S Methods and means for protecting the skin against pathogenic microorganisms

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8465731B2 (en) 2010-03-12 2013-06-18 Elc Management, Llc Probiotic color cosmetic compositions and methods

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1584694A (en) * 1976-05-21 1981-02-18 Seiken Kai Foundational Juridi Lactobacillus deodorant
US5269959A (en) * 1992-09-16 1993-12-14 Gary Schreibman Liquid deep cleaning detergent composition
FR2696932A1 (en) * 1992-10-19 1994-04-22 Sederma Sa Cosmetic compsns. contg. plant extracts and microbial culture filtrate - exhibits synergistic effects w.r.t. stimulating growth of fibroblasts, reducing depth of wrinkles and improving skin tone
FR2725896A1 (en) * 1994-10-19 1996-04-26 Sederma Sa Topical compsns. contg. microbial filtrates rich in glycine, arginine and creatine
WO1996038159A1 (en) * 1995-06-02 1996-12-05 Lafor Laboratories Limited Micro-encapsulated lactobacilli for medical applications
WO1998022082A1 (en) * 1996-11-22 1998-05-28 Cavaliere Widow Vesely Renata Sphingomyelinase compositions and use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52136909A (en) * 1976-05-06 1977-11-16 Ichirou Yamashita Preparation of cell activator
JP3129646B2 (en) * 1996-01-19 2001-01-31 鐘紡株式会社 Ceramide synthesis promoter

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1584694A (en) * 1976-05-21 1981-02-18 Seiken Kai Foundational Juridi Lactobacillus deodorant
US5269959A (en) * 1992-09-16 1993-12-14 Gary Schreibman Liquid deep cleaning detergent composition
FR2696932A1 (en) * 1992-10-19 1994-04-22 Sederma Sa Cosmetic compsns. contg. plant extracts and microbial culture filtrate - exhibits synergistic effects w.r.t. stimulating growth of fibroblasts, reducing depth of wrinkles and improving skin tone
FR2725896A1 (en) * 1994-10-19 1996-04-26 Sederma Sa Topical compsns. contg. microbial filtrates rich in glycine, arginine and creatine
WO1996038159A1 (en) * 1995-06-02 1996-12-05 Lafor Laboratories Limited Micro-encapsulated lactobacilli for medical applications
WO1998022082A1 (en) * 1996-11-22 1998-05-28 Cavaliere Widow Vesely Renata Sphingomyelinase compositions and use thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 127, no. 14, 6 October 1997 Columbus, Ohio, US; abstract no. 195256, XP002088527 & JP 09 194383 A (KANEBO LTD.) 29 July 1997 *
CHEMICAL ABSTRACTS, vol. 88, no. 16, 17 April 1978 Columbus, Ohio, US; abstract no. 110537, XP002088528 & JP 52 136909 A (YAMASHITA) 16 November 1977 *

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7510734B2 (en) 2004-03-04 2009-03-31 E-L Management Corporation Skin treatment method with Lactobacillus extract
EP2514427A1 (en) 2004-03-04 2012-10-24 E-L Management Corp. Skin treatment method with lactobacillus extract
WO2006136420A3 (en) * 2005-06-22 2007-04-19 Organobalance Gmbh Methods and means for protecting the skin against pathogenic microorganisms
EP1995307A1 (en) * 2005-06-22 2008-11-26 OrganoBalance GmbH Methods and means for protecting the skin against pathogenic microorganisms
KR101398347B1 (en) 2005-06-22 2014-05-22 오르가노발란스 게엠베하 Methods and means for protecting the skin against pathogenic microorganisms
CN101203600B (en) * 2005-06-22 2015-05-13 有机金属平衡有限公司 Methods and means for protecting the skin against pathogenic microorganisms
US10953051B2 (en) 2005-06-22 2021-03-23 Novozymes A/S Methods and means for protecting the skin against pathogenic microorganisms
WO2012118535A1 (en) 2011-03-01 2012-09-07 Quorum Innovations, Llc Materials and methods for treating conditions associated with pathogenic biofilm

Also Published As

Publication number Publication date
RO113114B1 (en) 1998-04-30
WO1999007332A3 (en) 1999-04-29
AU8753998A (en) 1999-03-01

Similar Documents

Publication Publication Date Title
US6905692B2 (en) Topical compositions containing probiotic bacillus bacteria, spores, and extracellular products and uses thereof
AU749001B2 (en) Topical use of probiotic bacillus spores to prevent or control microbial infections
TWI796304B (en) Composition for hair or scalp comprising lysate of lactobacillus plantarum
WO2018155660A1 (en) Composition containing dead cell bodies of lactic acid bacterium or treated product thereof, and cosmetic, household good, drug or food containing said composition
FR2718752A1 (en) Fermented whey product prepd. using mixt. of lactic acid bacteria and yeast
TWI750716B (en) Topical composition and its use for preparation of composition for improving skin disease and dermatitis
WO1999007332A2 (en) A natural eubiotic product for maintenance and treatment of teguments
JPS58225006A (en) Cosmetic for nourishing hair
JP3684205B2 (en) Lactococcus lactis CBT-19, method for producing antibacterial culture broth separation concentrate using the same, and cosmetic composition containing the same
JPS60190707A (en) Cariostatic agent
Hoffman et al. Scanning electron microscope studies of dextranase-treated plaque streptococci
CN113164531B (en) External preparation for promoting hair growth or preventing alopecia
JP3579134B2 (en) Cosmetics
JP2003113097A (en) External preparation including aureobasidium culture solution
AU2019425533A1 (en) Method for preparing fermented bean milk by leuconostoc mesenteroides (l. mesenteroides), prepared fermented bean milk and use thereof
AU2006201179B2 (en) Use of Emu Oil Carrier for Antifungal, Antibacterial, and Antiviral Medications
CN1281894A (en) Method for transferring human endostatin gene lactic bacteria, its product and application
WO1999007393A1 (en) Pharmaceutical product comprising bacterial strains for the colon therapy
JPS6270307A (en) Skin cosmetic
Frost et al. Present status of acidophilus milk
CN112889925A (en) Inactivated probiotic milk tablet and preparation method thereof
KR20230071706A (en) Cmposition for enhancing skin immunity and manufacturing method thereof
CN113546033A (en) Probiotic compound for promoting microecological balance and preparation method thereof
JPH02222674A (en) Method for maintaining microbial life
JPH03251171A (en) Production of noncariogenic microorganism and noncariogenic composition

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

AK Designated states

Kind code of ref document: A3

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 1999512023

Format of ref document f/p: F

NENP Non-entry into the national phase

Ref country code: CA

122 Ep: pct application non-entry in european phase